SG Americas Securities
VIGL

SG Americas Securities’s Vigil Neuroscience VIGL Stock Holding History

SG Americas Securities’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-43,508
Closed -$346K – 3579
2025
Q2 		$346K Buy
43,508
+22,091
+103% +$99K ﹤0.01% 1905
2025
Q1 		$38K Buy
+21,417
New +$48.1K ﹤0.01% 3299

Other funds holding VIGL

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

SG Americas Securities's VIGL Position: Q3 2025 in Review

SG Americas Securities sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 43,508 shares — an estimated $346K sold.

SG Americas Securities first reported a position in VIGL in Q1 2025 and held it in 2 quarters. The position peaked at $346K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

  • SG Americas Securities reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 43,508 Vigil Neuroscience shares in Q3 2025, an estimated $346K.
  • SG Americas Securities first reported a position in Vigil Neuroscience in Q1 2025 and held it in 2 quarters.
  • SG Americas Securities's Vigil Neuroscience position peaked at $346K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.